RECRUITINGOBSERVATIONAL
Chinese PE Multimodality Imaging Artificial Intelligence Study
CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study
About This Trial
The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.
Who May Be Eligible (Plain English)
Who May Qualify:
- 14 Years and older
- Patients suspected of PE
Who Should NOT Join This Trial:
- Pregnant women
- Refuse to follow up
- Incomplete or discontinued imaging scans
- Insufficient quality of image data to allow for analysis
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* 14 Years and older
* Patients suspected of PE
Exclusion Criteria:
* Pregnant women
* Refuse to follow up
* Incomplete or discontinued imaging scans
* Insufficient quality of image data to allow for analysis
Treatments Being Tested
DEVICE
Artificial Intelligence
AI technology will provide novel imaging markers and generate a radiology report with relevant key slice imaging and evaluation results
Locations (1)
China-Japan Frendship hospital
Beijing, China